🔥🐔 BizChicken 🐔🔥
Learn About the Corporations Around You
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Immunic, Inc.
Market Cap: Low
Employees: Low
IMU-838
Immunic, Inc. develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, in Phase 2 clinical trials for multiple conditions, including relapsing-remitting multiple sclerosis.
Website
About | Vision/Values | Contact | Contact | Contact | Careers | About | About | About | About | About
Symbol: IMUX
Recent Price: $1.03
Industry: Biotechnology
CEO: Dr. Daniel Vitt Ph.D.
Sector: Healthcare
Employees: 85
Address: 1200 Avenue of the Americas, New York, NY 10036
Phone: 332 255 9818
Last updated: 2024-12-31